Séverine Guiu

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Céline Lefèbvre, Thomas Bachelot, Thomas Filleron et al. · PLoS Medicine · 2016 · 388 citations · Full text

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer

Boris Guiu, J. Petit, F. Bonnetain et al. · Gut · 2009 · 256 citations

Visceral Fat Area as a New Independent Predictive Factor of Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Antiangiogenic Agents

Sylvain Ladoire, Franck Bonnetain, Mélanie Gauthier et al. · The Oncologist · 2011 · 170 citations · Full text

Prognostic Biomarkers, Urology, Angiogenesis +14

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact

Jean‐Marc Nabholtz, Catherine Abrial, Marie‐Ange Mouret‐Reynier et al. · Annals of Oncology · 2014 · 122 citations

Breast Oncology, Medicine, Treatment Impact +8

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases

William Jacot, Elvire Pons‐Tostivint, Jean‐Sébastien Frenel et al. · Breast Cancer Research and Treatment · 2016 · 117 citations

Breast Oncology, Brain Metastases, Medicine +8